Fulvestrant Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 250 mg/5 mL

Reference Brands: Faslodex® (EU & US)

Category: Oncology Cancer Care

Fulvestrant is available in Injection and strengths such as 250 mg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fulvestrant is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Fulvestrant can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Fulvestrant is a potent estrogen receptor antagonist used in the treatment of HR+ metastatic breast cancer in postmenopausal women. It is indicated for patients whose cancer has progressed after prior endocrine therapy. Marketed as Faslodex®, Fulvestrant is available in both the US and EU as a 250 mg/5 mL intramuscular injection, typically administered as 500 mg monthly. It works by binding and degrading estrogen receptors, thereby inhibiting cancer cell growth. Widely used in oncology hospitals and cancer centers, Fulvestrant is a valuable product for B2B pharmaceutical distribution in the oncology and specialty injectable segments.